KR20220114597A - 5-브로모피리딘-3-일-3-데옥시-3-[4-(3,4,5-트리플루오로페닐)-1H-1,2,3-트리아졸-1-일]-1-티오-α-D-갈락토피라노시드 및 이의 결정질 형태의 제조를 위한 대규모 공정 - Google Patents

5-브로모피리딘-3-일-3-데옥시-3-[4-(3,4,5-트리플루오로페닐)-1H-1,2,3-트리아졸-1-일]-1-티오-α-D-갈락토피라노시드 및 이의 결정질 형태의 제조를 위한 대규모 공정 Download PDF

Info

Publication number
KR20220114597A
KR20220114597A KR1020227023833A KR20227023833A KR20220114597A KR 20220114597 A KR20220114597 A KR 20220114597A KR 1020227023833 A KR1020227023833 A KR 1020227023833A KR 20227023833 A KR20227023833 A KR 20227023833A KR 20220114597 A KR20220114597 A KR 20220114597A
Authority
KR
South Korea
Prior art keywords
formula
compound
protecting group
base
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227023833A
Other languages
English (en)
Korean (ko)
Inventor
리세 그래벨
프레드릭 제터버그
앤드류 티렐
크리스틴 킨나트
알렉산더 웨이머스-윌슨
로버트 클락슨
Original Assignee
갈렉토 바이오테크 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 갈렉토 바이오테크 에이비 filed Critical 갈렉토 바이오테크 에이비
Publication of KR20220114597A publication Critical patent/KR20220114597A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1020227023833A 2019-12-16 2020-12-16 5-브로모피리딘-3-일-3-데옥시-3-[4-(3,4,5-트리플루오로페닐)-1H-1,2,3-트리아졸-1-일]-1-티오-α-D-갈락토피라노시드 및 이의 결정질 형태의 제조를 위한 대규모 공정 Pending KR20220114597A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19216405.1A EP3838909A1 (en) 2019-12-16 2019-12-16 Large scale process for the preparation of 5-bromopyridin-3-yl-3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]- 1-thio-alpha-d-galactopyranoside
EP19216405.1 2019-12-16
PCT/EP2020/086385 WO2021122719A1 (en) 2019-12-16 2020-12-16 Large scale process for the preparation of 5-bromopyridin-3-yl-3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]- 1-thio-alpha-d-galactopyranoside and a crystalline form thereof

Publications (1)

Publication Number Publication Date
KR20220114597A true KR20220114597A (ko) 2022-08-17

Family

ID=69024098

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227023833A Pending KR20220114597A (ko) 2019-12-16 2020-12-16 5-브로모피리딘-3-일-3-데옥시-3-[4-(3,4,5-트리플루오로페닐)-1H-1,2,3-트리아졸-1-일]-1-티오-α-D-갈락토피라노시드 및 이의 결정질 형태의 제조를 위한 대규모 공정

Country Status (7)

Country Link
US (1) US20230063538A1 (https=)
EP (2) EP3838909A1 (https=)
JP (2) JP7839730B2 (https=)
KR (1) KR20220114597A (https=)
CN (2) CN114929719A (https=)
CA (1) CA3160971A1 (https=)
WO (1) WO2021122719A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108558974B (zh) * 2018-04-28 2023-05-23 浙江树人学院 一种糖衍生吡啶三氮唑镍催化剂的制备及应用
WO2025180907A1 (en) 2024-02-26 2025-09-04 Galecto Biotech Ab Specific galactoside inhibitor of galectin-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2970062C (en) * 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
CA3025867A1 (en) * 2016-07-12 2018-01-18 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins

Also Published As

Publication number Publication date
JP2025111532A (ja) 2025-07-30
US20230063538A1 (en) 2023-03-02
JP7839730B2 (ja) 2026-04-02
EP4077343A1 (en) 2022-10-26
WO2021122719A1 (en) 2021-06-24
CN114929719A (zh) 2022-08-19
JP2023506066A (ja) 2023-02-14
CN120699068A (zh) 2025-09-26
EP3838909A1 (en) 2021-06-23
CA3160971A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
AU2023201821B2 (en) Modulators of the integrated stress pathway
KR20190039086A (ko) Bet 저해제의 결정질 고체 형태
KR102241258B1 (ko) 암을 치료하기 위한 1-테트라히드로피라닐카르보닐-2,3-디히드로-1h-인돌 화합물
JP7016809B2 (ja) 抗ウイルス剤としての四環式ピリドン化合物
JP2025111532A (ja) ５－ブロモピリジン－３－イル－３－デオキシ－３－［４－（３，４，５－トリフルオロフェニル）－１ｈ－１，２，３－トリアゾール－１－ｙｌ］－１－チオ－アルファ－ｄ－ガラクトピラノシド及びその結晶形を調製するための大規模方法
KR102331013B1 (ko) 퀴나졸리논 유도체, 이의 제조방법, 약학 조성물 및 적용
TW202115095A (zh) 新穎化合物
KR102473930B1 (ko) Trail 유도를 위한 약리단
UA121532C2 (uk) Способи і проміжні сполуки при отриманні інгібітора jak
EA032509B1 (ru) Замещенные индазолы, способы их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
EP3101020B1 (en) Deuterated quinazolinone compound and pharmaceutical composition comprising same
JP2021525810A (ja) トリプトファン異化のモジュレーター
EA029519B1 (ru) СВЯЗАННЫЕ С ГЕТЕРОЦИКЛИЛАМИ ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
JP6767589B1 (ja) 化合物の塩及びそれらの結晶
KR20230125006A (ko) 갈렉틴의 신규 갈락토시드 억제제
WO2025252743A1 (en) Novel galactoside inhibitor of galectins
WO2025252741A1 (en) Novel galactoside inhibitor of galectins
WO2022171561A1 (en) Novel galactoside inhibitor of galectins
RU2789377C2 (ru) Новые спиробициклические аналоги
RU2783211C2 (ru) Производные пиримидина в качестве ингибиторов активации pd1/pd-l1
CA3039178A1 (en) Novel jak1 selective inhibitors and uses thereof

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902